ArticleRSC advances2023

Engineering oncogene-targeted anisamide-functionalized pBAE nanoparticles as efficient lung cancer antisense therapies.

Cristina Fornaguera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.